Skip to main content

Closed

BIIB: Biogen Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

No data

Revenue growth-1.6% / yr

Operating margin5.6%

ROIC1.9%

Financially safe

Strong

Debt / equity0.44×

Interest coverage4.1×

Current ratio1.87×

Valuation

Unrated

P/E ratio1.4×

Biogen Inc.

BIIBNASDAQ Global Select·USD·Closed

Biogen Inc.

BIIBNASDAQ·USD·Closed

$202.95

−2.40%

$202.95

−$4.98 (2.40%)

52W Range

82thpctl

Volume

0.82×avg

Mkt Cap

29.99BUSD

P/E

1.4TTM

Div Yield

–ann

52W Range

82thpctl

Volume

0.82×avg

Market Cap

29.99BUSD

P/E Ratio

1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings